Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence.
case_control · Level III
Where this comes from
- Record sourced from PubMed, PMID 7490803.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We determined whether the sensitivity of detecting dysplasia or early bladder cancer can be improved by 5-aminolevulinic acid induced porphyrin fluorescence. A 3% 5-aminolevulinic acid solution was instilled intravesically before cystoscopy in 104 patients. The 5-aminolevulinic acid induced porphyrin fluorescence was excited by violet light from a krypton ion laser (wavelength 406.7 nm.). The sensitivity of the fluorescence cystoscopy (96.9%) was significantly (p < 0.0001) greater than that of white light cystoscopy (72.7%). There was no impact on specificity. Due to the high sensitivity of the procedure fluorescence guided biopsies are recommended instead of random biopsies.
Medical subject headings
- Aminolevulinic Acid
- Carcinoma in Situ
- Carcinoma, Transitional Cell
- Urinary Bladder
- Urinary Bladder Neoplasms